ASCC: Could Stem Cells Hold the Key to Unlocking $10 Billion Cosmetics Market
ASCC: Could Stem Cells Hold the Key to Unlocking $10 Billion Cosmetics Market
MIRAMAR BEACH, Fla.--(BUSINESS WIRE)-- The Aristocrat Group Corp.'s (OTCBB: ASCC) focus-group testing revealed that more and more women are seeking effective anti-aging treatments for their skin, and now the company believes it has found the perfect solution for the increase in cosmetic demand: Adult stem cells.
"Stem-cell products have all-natural regenerative powers that can't be matched by any chemical or botanical cooked up in a lab," said ASCC Cindy Morrissey. "The market for anti-aging treatments that really work is exploding worldwide, and by acquiring or partnering with cosmetic innovators working with stem cells, we plan to capitalize on this unstoppable trend."
U.S. demand for cosmetics and toiletries is forecast by some analysts to rise five percent annually to a total value of $9.9 billion by 2016. The organic and natural product segment as well as anti-aging products are both poised for rapid growth, in particular, as more and more baby boomers enter their 50s. As the population of older Americans grows, so, too, will the market for cosmetic products specifically formulated to improve the appearance of aging skin.
The key to capturing a profitable share of that market will be delivering a product that works with no side effects. ASCC is currently investigating new opportunities to help develop and market high-quality stem-cell cosmetics around the globe in order to deliver maximum returns to shareholders.
ASCC plans to expand its cosmetics business to compete in a highly profitable sector alongside Procter & Gamble (NYS: PG) , Unilever (NYS: UL) and Avon Products, Inc. (NYS: AVP) .
Follow ASCC on Twitter at www.twitter.com/AristocratGroup.
About the Aristocrat Group
The Aristocrat Group Corp. (www.aristocratgroupcorp.com) is a women's lifestyle company that aims to make the transition into parenthood smoother and more rewarding than ever before. Our smart growth initiatives will position us as the premier resource for prenatal and postpartum resources. For more information on our business plan, please visit www.aristocratgroupcorp.com/old/investor.html.
Notice Regarding Forward-Looking Statements
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone's past success, either financial or strategic, is no guarantee of future success. This news release speaks as of the date first set forth above and the company assumes no responsibility to update the information included herein for events occurring after the date hereof.
The Aristocrat Group Corp.
Cindy Morrissey, 850-269-6801
President and CEO
info@aristocratgroupcorp.com
KEYWORDS: United States North America Florida
INDUSTRY KEYWORDS:
The article ASCC: Could Stem Cells Hold the Key to Unlocking $10 Billion Cosmetics Market originally appeared on Fool.com.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.
